Clinical Trial

A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The study is being conducted to evaluate the efficacy, and safety of HRS-1893 for obstructive hypertrophic cardiomyopathy
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-07-17; most recent amendment 2025-07-15.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-04-20
Trial Details
NCT Number NCT06516068
Lead Sponsor Shandong Suncadia Medicine Co., Ltd.
Conditions Obstructive Hypertrophic Cardiomyopathy
Enrollment 42 participants
Start Date 2024-08-11
Primary Completion 2024-11-18 (estimated)
Study Completion 2025-08 (estimated)
Updated on ClinicalTrials.gov 2025-07-16